Clinical Trials Browser

OTHER × tocilizumab × 30 days × Clear all

NCT05233397 2026-04-08

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Phase 2 Recruiting

Craniopharyngioma